Trial Radar KI | ||
|---|---|---|
enums.trial_summary.trial_summary_welcome | ||
AMPLIFI: Adaptive Modulation of Plasticity Through Lactate and Fitness Interventions
All participants will complete motor learning tasks and undergo brain stimulation testing (using transcranial magnetic stimulation, or TMS) to assess how well the brain responds to training. The goal is to understand whether different types of exercise can improve brain function, movement, and memory, and how the body's response to exercise (like lactate levels) might support brain health.
This research may help identify low-cost, non-invasive interventions-such as targeted exercise-that improve motor and cognitive outcomes in aging and stroke recovery.
The primary outcome measure is cortical inhibition, assessed using transcranial magnetic stimulation (TMS) measures including short-interval intracortical inhibition (SICI), long-interval intracortical inhibition (LICI), and intracortical facilitation (ICF). Secondary outcomes include performance on upper extremity motor tasks, measures of verbal and executive function, and blood lactate levels.
Participants complete five sessions over 2-3 weeks, including baseline assessments, VO2 max testing, multiple blood draws, and cognitive and motor testing. The exercise intervention is delivered via stationary cycling at intensities tailored using individual VO2 max data and lactate monitoring. Genetic and biochemical assays will be performed on blood samples to explore associations between metabolic and neural response.
This study will clarify how lactate-related exercise intensity impacts cortical inhibition and whether those effects support improvements in motor learning. Findings may help define the mechanisms by which exercise promotes neuroplasticity and support individualized rehabilitation strategies for aging and post-stroke populations.
AMPLIFI: Adaptive Modulation of Plasticity Through Lactate and Fitness Interventions
- AMPLIFI
- IRB-300014361
Cortical Inhibition
Neuroplasticity
Aerobic Exercise
Motor Learning
Aging
Stroke Rehabilitation
Cortical Excitability
GABAergic Inhibition
| Teilnehmergruppe/Studienarm | Intervention/Behandlung |
|---|---|
ExperimentellAerobic Exercise at Lactate Threshold Participants complete a 20-minute aerobic cycling session at individually prescribed intensity to achieve lactate threshold, based on VO2 max and blood lactate data. This condition is designed to induce metabolic stress and engage neuromodulatory pathways related to cortical plasticity. Participants complete TMS and motor learning tasks before and after the intervention. | Moderate-to-high Intensity Cycling Participants cycle on a stationary ergometer at an intensity prescribed to reach their lactate threshold, guided by VO2 max results and lactate sampling. The session lasts approximately 20 minutes and is preceded and followed by TMS assessments and a structured motor learning task. This condition is designed to evaluate the effect of exercise-induced metabolic stress on cortical inhibition and motor learning. |
Aktives VergleichspräparatLow-Intensity Aerobic Exercise Participants complete a 20-minute cycling session at a light workload, below lactate threshold. This condition controls for movement and engagement without significant metabolic challenge. TMS and motor learning outcomes are assessed pre- and post-intervention. | Low-intensity Cycling Participants perform 20 minutes of cycling at a light workload below their lactate threshold. Exercise intensity is individualized using heart rate and perceived exertion (Borg RPE scale), avoiding significant metabolic activation. TMS and motor learning are assessed pre- and post-exercise. This condition serves as an active comparator to assess the impact of exercise intensity. |
Placebo-VergleichspräparatEducation Control Participants engage in a 20-minute health education session instead of exercise. This arm serves as a non-exercise control to isolate the effects of physical exertion on neuroplasticity. All outcome measures are collected similarly to the exercise groups. | Health Education Session Participants receive a 20-minute session of health education content (e.g., wellness, healthy aging). No exercise is performed. Participants undergo TMS and motor learning testing before and after the session. This condition is used to control for attention and cognitive engagement without physical activity. |
| Ergebnismessung | Beschreibung der Messung | Zeitrahmen |
|---|---|---|
Motor Learning Performance (12-Digit Serial Reaction Time Task) | Motor learning is assessed using the 12-digit Serial Reaction Time Task (SRTT), a computer-based measure of implicit motor sequence learning. Participants respond to visual cues by pressing buttons in a fixed or random sequence. Learning is quantified by changes in reaction time and accuracy across structured and unstructured trials. A learning index is derived by comparing performance between patterned (learning) and random sequences. | Baseline, Day 2, Day 3, Day 4, and Day 5 |
| Ergebnismessung | Beschreibung der Messung | Zeitrahmen |
|---|---|---|
Change in Long-Interval Intracortical Inhibition (LICI) | LICI is measured using a 100 ms interstimulus interval to assess GABA\<sub\>B\</sub\>-mediated inhibition. Recorded before and after each intervention session. | Baseline, Day 5 |
Change in Intracortical Facilitation (ICF) | ICF is assessed using paired-pulse TMS with a 10-15 ms interstimulus interval to evaluate cortical excitability. | Baseline, Day 5 |
Change in Blood Lactate Concentration | Measured via fingerstick blood samples pre-, mid-, and post-exercise. | Day 2, Day 3, Day 4 |
Change in Executive Function (D-KEFS Verbal Fluency and Stroop Tests) | Executive function neuropsychological tests. | Day 1 and Day 5 |
For All Participants:
- Able to provide informed consent
- Right-handed (for TMS consistency)
- English-speaking
- Clearance for moderate-intensity aerobic exercise
- Able to safely sit and pedal a stationary cycle ergometer
- No contraindications to TMS (e.g., no metal in skull, pacemakers, or seizure history)
Younger Adults (18-35):
- No history of neurological or psychiatric conditions
- Not currently on medications that affect the central nervous system
Older Adults (60-85):
- No diagnosis of dementia
- Independent in activities of daily living
- No stroke history
Stroke Survivors (18-85):
- At least 6 months post-stroke (chronic phase)
- Medically stable and cleared for aerobic exercise
- Able to engage in motor learning task (with or without hemiparetic adaptations)
- History of epilepsy or seizures
- Current substance abuse or uncontrolled psychiatric disorder
- Severe cardiovascular disease or unstable medical condition
- Pregnancy
- Contraindications to TMS or exercise testing (e.g., implanted neurostimulators, severe hypertension)
- Participation in another interventional trial within the past 30 days
Alabama